Makes even the toughest topics accessible.
This comment is not public.
Andrew Kozlov, MD, serves as Assistant Professor (Clinical) in the Department of Radiology and Imaging Sciences at the University of Utah School of Medicine. He holds the position of Interim Section Chief of Breast Imaging and Director of the Women's Imaging Fellowship Program. An expert in cancer imaging, Dr. Kozlov is double board-certified in diagnostic radiology by the American Board of Radiology and in nuclear medicine by the American Board of Nuclear Medicine. His clinical proficiencies include computed tomography, mammography, nuclear medicine, digital breast tomosynthesis, breast imaging, image-guided biopsy, magnetic resonance imaging, and radiology. He is listed among the faculty in both the breast imaging and nuclear medicine sections of the department.
Dr. Kozlov received his B.A. from Northwestern University and M.D. from the University of Florida College of Medicine. He completed a transitional internship at Presence St. Francis Hospital, followed by a residency in the dual certification pathway for diagnostic radiology and nuclear radiology at the Hospital of the University of Pennsylvania, where he later served as Chief Fellow in nuclear medicine. He undertook an additional fellowship in breast imaging at Stanford University School of Medicine. His scholarly contributions feature peer-reviewed publications focused on breast imaging techniques, mammography quality, tumor assessment, and related diagnostic advancements. Notable works include 'Sustaining Mammography Image Quality With a Technologist Coaching Program in the Era of the Enhancing Quality Using the Inspection Program (EQUIP)' (2023, Journal of Breast Imaging), 'A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death' (2025, NPJ Breast Cancer), 'Tumor volume doubling time estimated from digital breast tomosynthesis mammograms distinguishes invasive breast cancers from benign lesions' (2023, European Radiology), 'Perfusion-only imaging in pregnant women: A comparative reader study with implications for practice patterns' (2022, Medicine), and 'Preoperative breast MR imaging in newly diagnosed breast cancer: Comparison of outcomes based on mammographic modality, breast density and breast parenchymal enhancement' (2021, Clinical Imaging). Additional research spans gut microbiota analysis in hematopoietic cell transplantation and molecular identification of bacteria in abscesses. Through his roles in clinical practice, education, and research at University of Utah Health, Dr. Kozlov advances standards in breast imaging and nuclear medicine.
